Alteration in PI3K/mTOR, MAPK pathways and Her2 expression/amplification is more frequent in uterine serous carcinoma than ovarian serous carcinoma

Publisher： John Wiley & Sons Inc

E-ISSN： 1096-9098|112|2|188-194

ISSN： 0022-4790

Source： JOURNAL OF SURGICAL ONCOLOGY, Vol.112, Iss.2, 2015-08, pp. : 188-194

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Gene amplification, mutation, and protein expression of EGFR and mutations of ERBB2 in serous ovarian carcinoma

By Lassus Heini   Sihto Harri   Leminen Arto   Joensuu Heikki   Isola Jorma   Nupponen Nina   Butzow Ralf  

Journal of Molecular Medicine, Vol. 84, Iss. 8, 2006-08 ,pp. : 671-681

Springer Publishing Company

Access to resources Recommend Favorite

Dual PI3K/mTOR inhibitor NVP-BEZ235-induced apoptosis of hepatocellular carcinoma cell lines is enhanced by inhibitors of autophagy

By                

International Journal of Molecular Medicine, Vol. 31, Iss. 6, 2013-01 ,pp. : 1449-1456

Spandidos Publications

Access to resources Recommend Favorite

Immunohistochemical and molecular analysis of PI3K/AKT/mTOR pathway in esophageal carcinoma

By  

APMIS (ELECTRONIC), Vol. 123, Iss. 8, 2015-08 ,pp. : 639-647

John Wiley & Sons Inc

Access to resources Recommend Favorite

Combined hepatoid and serous carcinoma of the uterine corpus: an undescribed phenomenon

By  

HISTOPATHOLOGY, Vol. 67, Iss. 1, 2015-07 ,pp. : 135-137

John Wiley & Sons Inc

Access to resources Recommend Favorite

PI3K/PTEN/AKT/mTOR polymorphisms: Association with clinical outcome in patients with head and neck squamous cell carcinoma receiving cetuximab‐docetaxel

By  

HEAD & NECK: JOURNAL FOR THE SCIENCES & SPECIALTIES OF THE HEAD AND NECK, Vol. 37, Iss. 4, 2015-04 ,pp. : 471-478

John Wiley & Sons Inc

Access to resources Recommend Favorite